Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer

The insulin-like growth factor-2 mRNA-binding protein 1 (IGF2BP1) plays essential roles in embryogenesis and carcinogenesis. IGF2BP1 serves as a post-transcriptional fine-tuner regulating the expression of some essential mRNA targets required for the control of tumor cell proliferation and growth, invasion, and chemo-resistance, associating with a poor overall survival and metastasis in various types of human cancers. Therefore, IGF2BP1 has been traditionally regarded as an oncogene and potential therapeutic target for cancers. Nevertheless, a few studies have also demonstrated its tumor-suppressive role. However, the details about the contradictory functions of IGF2BP1 are unclear. The growing numbers of microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) have been identified as its direct regulators, during tumor cell proliferation, growth, and invasion in multiple cancers. Thus, the mechanisms of post-transcriptional modulation of gene expression mediated by IGF2BP1, miRNAs, and lncRNAs in determining the fate of the development of tissues and organs, as well as tumorigenesis, need to be elucidated. In this review, we summarized the tissue distribution, expression, and roles of IGF2BP1 in embryogenesis and tumorigenesis, and focused on modulation of the interconnectivity between IGF2BP1 and its targeted mRNAs or non-coding RNAs (ncRNAs). The potential use of inhibitors of IGF2BP1 and its related pathways in cancer therapy was also discussed.

[1]  D. Kufe,et al.  MUC1-C Induces the LIN28B→LET-7→HMGA2 Axis to Regulate Self-Renewal in NSCLC , 2014, Molecular Cancer Research.

[2]  M. Groszer,et al.  PTEN deletion in Bergmann glia leads to premature differentiation and affects laminar organization , 2005, Development.

[3]  G. Brewer,et al.  Targeted Knockdown of the RNA-binding Protein CRD-BP Promotes Cell Proliferation via an Insulin-like Growth Factor II-dependent Pathway in Human K562 Leukemia Cells* , 2004, Journal of Biological Chemistry.

[4]  H. M. El Tayebi,et al.  miR‐1275: A single microRNA that targets the three IGF2‐mRNA‐binding proteins hindering tumor growth in hepatocellular carcinoma , 2015, FEBS letters.

[5]  Hong-yan Liu,et al.  Modulation of IGF2BP1 by long non-coding RNA HCG11 suppresses apoptosis of hepatocellular carcinoma cells via MAPK signaling transduction , 2017, International journal of oncology.

[6]  G. Daley,et al.  Lin28: A MicroRNA Regulator with a Macro Role , 2010, Cell.

[7]  P. Schirmacher,et al.  Insulin‐like growth factor 2 mRNA‐binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma , 2014, Hepatology.

[8]  Ping Wang,et al.  MicroRNA-124-3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1 , 2017, Experimental and therapeutic medicine.

[9]  Samir Adhikari,et al.  Nuclear m(6)A Reader YTHDC1 Regulates mRNA Splicing. , 2016, Molecular cell.

[10]  Liang Li,et al.  Downregulation of long non-coding RNA HCG11 predicts a poor prognosis in prostate cancer. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[11]  L. Meng,et al.  SOX12 upregulation is associated with metastasis of hepatocellular carcinoma and increases CDK4 and IGF2BP1 expression. , 2017, European review for medical and pharmacological sciences.

[12]  R. Korneluk,et al.  IGF2BP1 controls cell death and drug resistance in rhabdomyosarcomas by regulating translation of cIAP1 , 2014, Oncogene.

[13]  M. Göke,et al.  Intestinal fibroblasts regulate intestinal epithelial cell proliferation via hepatocyte growth factor. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[14]  Amber L. Wells,et al.  Feedback Regulation between Zipcode Binding Protein 1 and β-Catenin mRNAs in Breast Cancer Cells , 2008, Molecular and Cellular Biology.

[15]  E. Levine,et al.  The let-7–Imp axis regulates ageing of the Drosophila testis stem-cell niche , 2012, Nature.

[16]  Bing Ren,et al.  N6-methyladenosine-dependent regulation of messenger RNA stability , 2013 .

[17]  Feng Yang,et al.  Long non‐coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c‐Myc mRNA stability , 2014, The FEBS journal.

[18]  S. Almo,et al.  ZBP1 recognition of beta-actin zipcode induces RNA looping. , 2010, Genes & development.

[19]  Mark J. Bowser,et al.  IMP-1 displays cross-talk with K-Ras and modulates colon cancer cell survival through the novel proapoptotic protein CYFIP2. , 2011, Cancer research.

[20]  M. Kuo,et al.  Function and regulation of let-7 family microRNAs. , 2012, MicroRNA.

[21]  Zheng Wang,et al.  Long non-coding RNAs as prognostic markers in human breast cancer , 2016, Oncotarget.

[22]  J. Xiong,et al.  MicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasis , 2016, Oncotarget.

[23]  Stefan Hüttelmaier,et al.  Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? , 2012, Cellular and Molecular Life Sciences.

[24]  A. English,et al.  Limited availability of ZBP1 restricts axonal mRNA localization and nerve regeneration capacity , 2011, The EMBO journal.

[25]  B. Xiong,et al.  Prognostic and clinicopathological significance of microRNA-494 overexpression in cancers: a meta-analysis , 2017, Oncotarget.

[26]  Y. Shimada,et al.  Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer , 2014, British Journal of Cancer.

[27]  KyungMann Kim,et al.  Targeting insulin‐like growth factor 2 mRNA‐binding protein 1 (IGF2BP1) in metastatic melanoma to increase efficacy of BRAFV600E inhibitors , 2018, Molecular carcinogenesis.

[28]  A. Eidukaitė,et al.  ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia. , 2016, Blood cells, molecules & diseases.

[29]  Cheng Huang,et al.  Long noncoding RNAs: Novel insights into hepatocelluar carcinoma. , 2014, Cancer letters.

[30]  T. Hansen,et al.  Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer. , 2005, Reproduction.

[31]  N. Bhatia,et al.  Overexpression of mRNA-binding protein CRD-BP in malignant melanomas , 2008, Oncogene.

[32]  Yusuke Nakamura,et al.  Increased Expression of Insulin-like Growth Factor-II Messenger RNA–Binding Protein 1 Is Associated with Tumor Progression in Patients with Lung Cancer , 2007, Clinical Cancer Research.

[33]  Avtar Roopra,et al.  Two Isoforms of the RNA Binding Protein, Coding Region Determinant-binding Protein (CRD-BP/IGF2BP1), Are Expressed in Breast Epithelium and Support Clonogenic Growth of Breast Tumor Cells* , 2015, The Journal of Biological Chemistry.

[34]  R. Singer,et al.  IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling. , 2012, Genes & development.

[35]  A. Madugundu,et al.  Proteomic profiling of retinoblastoma by high resolution mass spectrometry , 2016, Clinical Proteomics.

[36]  Chuan He,et al.  N 6 -methyladenosine Modulates Messenger RNA Translation Efficiency , 2015, Cell.

[37]  D. Gutmann,et al.  Pten Loss Causes Hypertrophy and Increased Proliferation of Astrocytes In vivo , 2004, Cancer Research.

[38]  J. Yun,et al.  miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma , 2014, Oncogene.

[39]  P. Comoglio,et al.  A positive feedback loop between hepatocyte growth factor receptor and β-catenin sustains colorectal cancer cell invasive growth , 2007, Oncogene.

[40]  L. Trusolino,et al.  MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors. , 2014, Cancer research.

[41]  C. A. Hickey,et al.  Imp (IGF-II mRNA-Binding Protein) Is Expressed During Spermatogenesis in Drosophila melanogaster , 2008, Fly.

[42]  Rong-peng Dong,et al.  MicroRNA-150 functions as a tumor suppressor in osteosarcoma by targeting IGF2BP1 , 2016, Tumor Biology.

[43]  T. Tan,et al.  Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia , 2017, Journal of Hematology & Oncology.

[44]  S. Hüttelmaier,et al.  Subcellular localization and RNP formation of IGF2BPs (IGF2 mRNA-binding proteins) is modulated by distinct RNA-binding domains , 2013, Biological chemistry.

[45]  C. Mao,et al.  A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation , 2017, Translational oncology.

[46]  S. Hauptmann,et al.  Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma , 2007, Oncogene.

[47]  Jianbiao Zhou,et al.  LIN28/LIN28B: an emerging oncogenic driver in cancer stem cells. , 2013, The international journal of biochemistry & cell biology.

[48]  A. Fainsod,et al.  The RNA-binding protein Vg1 RBP is required for cell migration during early neural development , 2003, Development.

[49]  G. Nasioulas,et al.  Expression of the RNA-binding protein CRD-BP in brain and non-small cell lung tumors. , 2004, Cancer letters.

[50]  S. Perez,et al.  Potential Prognostic Molecular Signatures in a Preclinical Model of Melanoma. , 2017, Anticancer research.

[51]  J. Schulte,et al.  IGF2BP1 harbors prognostic significance by gene gain and diverse expression in neuroblastoma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  R. Darnell,et al.  Two ZBP1 KH domains facilitate β-actin mRNA localization, granule formation, and cytoskeletal attachment , 2003, The Journal of cell biology.

[53]  Y. Hsieh,et al.  IMP1 promotes choriocarcinoma cell migration and invasion through the novel effectors RSK2 and PPME1. , 2013, Gynecologic oncology.

[54]  Yong-jig Cho,et al.  CYFIP2, a Direct p53 Target, is Leptomycin-B Sensitive , 2007, Cell cycle.

[55]  Jing Sun,et al.  Expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins in non–small cell lung cancer , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[56]  E. Berns,et al.  MicroRNAs in ovarian cancer biology and therapy resistance. , 2010, The international journal of biochemistry & cell biology.

[57]  Mark I. McCarthy,et al.  Genome-Wide Association Study Reveals Multiple Loci Associated with Primary Tooth Development during Infancy , 2010, PLoS genetics.

[58]  J.-L. Huang,et al.  Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma. , 2014, Carcinogenesis.

[59]  Robert Reihs,et al.  IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer , 2017, Oncotarget.

[60]  Ligang Wu,et al.  YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4–NOT deadenylase complex , 2016, Nature Communications.

[61]  Qi Long,et al.  Comparative transcriptomes of adenocarcinomas and squamous cell carcinomas reveal molecular similarities that span classical anatomic boundaries , 2017, PLoS genetics.

[62]  A. Antsaklis,et al.  IGF2BP1 expression in human mesenchymal stem cells significantly affects their proliferation and is under the epigenetic control of TET1/2 demethylases. , 2014, Stem cells and development.

[63]  J. Condeelis,et al.  ZBP1 enhances cell polarity and reduces chemotaxis , 2007, Journal of Cell Science.

[64]  Stefan Hüttelmaier,et al.  Recognition of RNA N6-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation , 2018, Nature Cell Biology.

[65]  Jiajia Zhang,et al.  Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients. , 2017, Cancer biomarkers : section A of Disease markers.

[66]  G. Barnett,et al.  Methylation markers of malignant potential in meningiomas. , 2013, Journal of neurosurgery.

[67]  J. Zavadil,et al.  Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. , 2002, Cancer research.

[68]  Hao-dong Xu,et al.  The use of insulin like-growth factor II messenger RNA binding protein-3 in diagnostic pathology. , 2011, Human pathology.

[69]  X. Morin,et al.  Motility Screen Identifies Drosophila IGF-II mRNA-Binding Protein—Zipcode-Binding Protein Acting in Oogenesis and Synaptogenesis , 2008, PLoS genetics.

[70]  Huynh-Hoa Bui,et al.  Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA , 2017, Cell.

[71]  F. Nielsen,et al.  RNA‐binding IMPs promote cell adhesion and invadopodia formation , 2006, The EMBO journal.

[72]  J. Silke,et al.  Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation. , 2013, Cold Spring Harbor perspectives in biology.

[73]  M. Kupiec,et al.  Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq , 2012, Nature.

[74]  C. Thomssen,et al.  The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family , 2016, Nucleic acids research.

[75]  R. Sun,et al.  miR-506 inhibits the proliferation and invasion by targeting IGF2BP1 in glioblastoma. , 2015, American journal of translational research.

[76]  Ren-Jie Wang,et al.  MicroRNA-873 (MiRNA-873) Inhibits Glioblastoma Tumorigenesis and Metastasis by Suppressing the Expression of IGF2BP1 , 2015, The Journal of Biological Chemistry.

[77]  K. Miyata,et al.  MicroRNA‐494 suppresses cell proliferation and induces senescence in A549 lung cancer cells , 2012, Cell proliferation.

[78]  Xufeng Zhang,et al.  MicroRNA-98-5p Inhibits Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma via Targeting IGF2BP1 , 2017, Oncology research.

[79]  Kiyoshi Saito,et al.  Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses. , 2012, Carcinogenesis.

[80]  M. Shahjahani,et al.  The Role of microRNAs in Stemness of Cancer Stem Cells , 2013, Oncology reviews.

[81]  M. Rebucci,et al.  miRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1 , 2015, Molecular Cancer.

[82]  Zhike Lu,et al.  m6A-dependent regulation of messenger RNA stability , 2013, Nature.

[83]  J. Jaworski,et al.  Zipcode Binding Protein 1 Regulates the Development of Dendritic Arbors in Hippocampal Neurons , 2011, The Journal of Neuroscience.

[84]  Jan Christiansen,et al.  Sequential dimerization of human zipcode-binding protein IMP1 on RNA: a cooperative mechanism providing RNP stability. , 2004, Nucleic acids research.

[85]  Hong Zhang,et al.  MicroRNAs-491-5p suppresses cell proliferation and invasion by inhibiting IGF2BP1 in non-small cell lung cancer. , 2016, American journal of translational research.

[86]  S. Hüttelmaier,et al.  IGF2BP1: a post-transcriptional "driver" of tumor cell migration. , 2012, Cell adhesion & migration.

[87]  B. Tang,et al.  The emergence of long non-coding RNAs in the tumorigenesis of hepatocellular carcinoma. , 2015, Cancer letters.

[88]  Tianxiang Chen,et al.  LncRNAs: emerging biomarkers in gastric cancer. , 2015, Future oncology.

[89]  John S. Condeelis,et al.  Identification and Testing of a Gene Expression Signature of Invasive Carcinoma Cells within Primary Mammary Tumors , 2004, Cancer Research.

[90]  N. Grishin,et al.  NESdb: a database of NES-containing CRM1 cargoes , 2012, Molecular biology of the cell.

[91]  D. Sela-Donenfeld,et al.  A Novel Role for VICKZ Proteins in Maintaining Epithelial Integrity during Embryogenesis , 2015, PloS one.

[92]  Zhengyang Guo,et al.  Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma , 2015, Oncotarget.

[93]  W. Gu,et al.  Blocking β-catenin binding to the ZBP1 promoter represses ZBP1 expression, leading to increased proliferation and migration of metastatic breast-cancer cells , 2009, Journal of Cell Science.

[94]  Lin-lin Sun,et al.  Restoration of microRNA‐708 sensitizes ovarian cancer cells to cisplatin via IGF2BP1/Akt pathway , 2017, Cell biology international.

[95]  M. Lederer,et al.  The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer. , 2014, Seminars in cancer biology.

[96]  Sevim Ozgur,et al.  Posttranscriptional destabilization of the liver‐specific long noncoding RNA HULC by the IGF2 mRNA‐binding protein 1 (IGF2BP1) , 2013, Hepatology.

[97]  Lin Zhang,et al.  Double-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cells. , 2010, Cancer research.

[98]  A. Adjei,et al.  K-ras as a target for cancer therapy. , 2005, Biochimica et biophysica acta.

[99]  A. Rustgi,et al.  IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenografts. , 2013, Carcinogenesis.

[100]  W. Gu,et al.  IMP1 suppresses breast tumor growth and metastasis through the regulation of its target mRNAs , 2016, Oncotarget.

[101]  A. Rustgi,et al.  Loss of Stromal IMP1 Promotes a Tumorigenic Microenvironment in the Colon , 2015, Molecular Cancer Research.

[102]  A. Sood,et al.  XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A , 2015, Clinical Cancer Research.

[103]  Amber L. Wells,et al.  Regulation of local expression of cell adhesion and motility-related mRNAs in breast cancer cells by IMP1/ZBP1 , 2012, Journal of Cell Science.

[104]  John T. Powers,et al.  Lin28 Enhances Tumorigenesis and is Associated With Advanced Human Malignancies , 2009, Nature Genetics.

[105]  T. Hansen,et al.  Dwarfism and Impaired Gut Development in Insulin-Like Growth Factor II mRNA-Binding Protein 1-Deficient Mice , 2004, Molecular and Cellular Biology.